Infrainguinal bypass conduit: Autogenous or synthetic - A national perspective

Vascular and Endovascular Surgery

Volumn 36, Issue 4, 2002, Pages 247-254

  Merrell, Greg A ^a   Gusberg, Richard J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSEL GRAFT; BYPASS SURGERY; CIGARETTE SMOKING; DATA BASE; DIABETES MELLITUS; FEMORAL ARTERY; FEMOROTIBIAL BYPASS; HEALTH MAINTENANCE ORGANIZATION; HOSPITAL BILLING; HUMAN; MEDICARE; PERIPHERAL VASCULAR DISEASE; POPLITEAL ARTERY; PREVALENCE; REVIEW; SURGICAL TECHNIQUE; TIBIAL ARTERY; VASCULAR DISEASE; VASCULAR SURGERY; VEIN ANASTOMOSIS;

EID: 0036661325     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/153857440203600401     Document Type: Review

References (20)

1. Veith FJ, Gupta SK, Ascer E, et al: Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 3:104-114, 1986.
2. McCollum CN, Kenchinton G, Alexander CE, et al: PTFE or HUV for femoropopliteal bypass: A multicentre trial. Eur J Vasc Surg 5:435-443, 1991.
3. Quinones-Baldrich WJ, Prego AA, Ucelay-Gomez R, et al: Long-term results of infrainguinal revascularization with polytetrafluoroethylene: A ten-year experience. J Vasc Surg 16:209-217, 1992.
4. Quinones-Baldrich WJ, Busuttil RW, Baker JD, et al: Is the preferential use of polytetrafluoroethylene grafts for femoropopliteal bypass justified? J Vasc Surg 8:219-228, 1988.
5. Patterson RB, Fowl RJ, Kempczinski RF, et al: Preferential use of ePTFE for above-knee femoropopliteal bypass grafts. Ann Vasc Surg 4:338-343, 1990.
6. Prendiville EJ, Yeager A, O'Donnell TF Jr, et al: Long-term results with the above-knee popliteal expanded polytetrafluoroethylene graft. J Vasc Surg 11:517-524, 1990.
7. Sterpetti AV, Schultz RD, Feldhaus RJ, et al: Seven year experience with polytetrafluoroethylene as above-knee femoropopliteal bypass graft. Is it worthwhile to preserve the autogenous saphenous vein? J Vasc Surg 2:907-912, 1985.
8. Abbott WM, Green RM, Matsumoto T, et al: Prosthetic above-knee femoropopliteal bypass grafting: Results of a multicenter randomized prospective trial. J Vasc Surg 25:19-28, 1997.
9. Cochrane Peripheral Vascular Diseases Group: Graft type for femoro-popliteal bypass surgery. The Cochrane Database of Systemic Reviews. 4:1-17, 1999.
10. Hunink GM, Cullen KA, Donaldson MC: Hospital costs of revascularization procedures for femoropopliteal arterial disease. J Vasc Surg 19:632-641, 1994.
11. Hunink GM, Wong JB, Donaldson MC, et al: Revascularization for femoropopliteal disease. JAMA 274:165-171, 1995.
12. Stansel HC, Fenn JE, Tilson MD, et al: Surgical principles and polytetrafluoroethylene. Arch Surg 114:1291-1294, 1979.
13. Bergan JJ, Veith FJ, Bernhard VM, et al: Randomization of autogenous vein and polytetrafluoroethylene grafts in femoral distal reconstruction. Surgery 92:921-930, 1982.
14. Leather RP, Shah DM, Chang BB, et al: Resurrection of the in situ saphenous vein bypass: 1000 cases later. Ann Surg 208:435-442, 1988.
15. Kent KC, Whittemore AD, Mannick JA: Short-term and mid-term results of an all-autologous tissue policy for infrainguinal reconstruction. J Vasc Surg 9:107-114, 1989.
16. Taylor LM Jr, Edward JM, Porter JM: Present status of reversed vein bypass grafting: Five-year results of a modern series. J Vasc Surg 11:193-206, 1990.
17. Gupta SK, Veith FJ, Kram HB, et al: Prospective randomized comparison of ringed and nonringed polytetrafluoroethylene femoropopliteal bypass grafts: A preliminary report. J Vasc Surg 13:162-172, 1991.
18. Donaldson MC, Whittemore AD, Mannick JA: Further experience with an all-autogenous tissue policy for infrainguinal reconstruction. J Vasc Surg 18:41-48, 1993.
19. Whittemore AD, Kent KC, Donaldson MC, et al: What is the proper role of polytetrafluoroethylene graft. J Vasc Surg 10:299-305, 1989.
20. Pomposelli FB Jr, Marcaccio EJ, Gibbons GW, et al: Dorsalis pedis arterial bypass: Durable limb salvage for foot ischemia in patients with diabetes mellitus. J Vasc Surg 21:375-384, 1995.